Matt Iuliano: Jockey Club supports phase out of Lasix, wants clean competition
Matt F. Iuliano, the executive director and executive vice president of the Jockey Club, addresses the use of race day medication and the impact it is having on the sport of horse racing. At present, both New York and Kentucky are considering changes to their stance on the use of Lasix. New York held an open comment period and Kentucky will likely vote at a meeting on Wednesday on whether or not to begin a phaseout of the drug. Iuliano writes that the Jockey Club has long supported a gradual phase out of the use of Lasix.
Jockey Club hired the consulting firm McKinsey & Company to review the sport of horse racing and make recommendations for improvement. The analysis showed a loss of 4 percent of fans per year with safety and welfare and medication the most common reasons for people to leave the sport. Of current fans, “78 percent said they would stop betting if they knew horses were not treated well; 38 percent said they would bet more if they knew horses were not given drugs, and 36 percent said drugs is one of the top three issues facing racing.”
Iuliano encourages Kentucky to seize the opportunity to become a leader in the movement for clean competition in horse racing.